I totally agree with Dr. Schuman’s perspective in his article that “it is inappropriate and irresponsible for pediatricians [and I include, PNPs] to encourage the use of cannabidiol (CBD) until more studies are available” to assure the safety and efficacy of CBD are clearly established in rigorous randomized controlled clinical trials.
Want your own print copy of Contemporary Pediatrics?
We’re offering special discounted rate for a print subscription of Contemporary Pediatrics. $45 brings 12 issues of Contemporary Pediatrics to your mailbox. Order now by emailing cradwan@mmhgroup.com
Many treatments for warts are destructive and painful, and are more likely to cause complications than the warts. A pediatric dermatologist advises what to do—or not do—for common warts.
There is little evidence of efficacy and safety of the cannabidiol products flooding the market when it comes to use in children. Here’s what pediatricians should know and what to tell parents.
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: %%Member_Busname%% %%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%